Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03358290 · TERMINATED
Trial details
- NCT number
- NCT03358290
- Sponsor
- Akros Pharma Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-10
- Primary completion
- 2018-10-29
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.